TO-901317

TO-901317 Uses, Dosage, Side Effects, Food Interaction and all others data.

TO-901317 is an LXRalpha and LXRbeta agonist.

Trade Name TO-901317
Generic TO-901317
Type
Formula C17H12F9NO3S
Weight Average: 481.333
Monoisotopic: 481.03941779
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
TO-901317
TO-901317

Innovators Monograph

You find simplified version here TO-901317



https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:39976
http://www.genome.jp/dbget-bin/www_bget?cpd:C15630
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=447912
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443551
https://www.chemspider.com/Chemical-Structure.394870.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19993
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL62136
https://zinc.docking.org/substances/ZINC000001550221
http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2755
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/444
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL
beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide
N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide
2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID
4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide
N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide
(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE
Visual field
Diabetic Foot Exam
Sputum fungal smear
PBG urine test
D-dimer test
Indium-labelled WBC scan
PET scan
Electrocardiogram
TSI test
V/Q Scan
Heterozygous familial hyperlipidemia
Benign Prostatic Hypertrophy
Obstructive Hypertrophic Cardiomyopathy
Herpes simplex of the oral-labial
Skin hyperpigmentation
Lip moisturizing
Candidiasis
Juvenile
Serious infections
Creatinine Clearance 5-15 mL/min